Vidyya Medical News Service
*
Volume 5 Issue 269 Published - 14:00 UTC 08:00 EST 26-Sep-2003 Next Update - 14:00 UTC 08:00 EST 27-Sep-2003
little clear gif used for spacer
.
*

Coronary bypass surgery results in better 5-year outcomes than coronary angioplasty
Previous studies have not shown any substantial difference in how coronary artery disease (CAD) patients fare 2 to 3 years after either coronary artery bypass graft (CABG) surgery or percutaneous transluminal coronary angioplasty (PTCA), two procedures that are performed to restore adequate blood supply to blocked arteries. more

*
Nonsmokers and previous smokers have less angina and function better physically than smokers after coronary angioplasty
Nonsmokers and former smokers (including those who quit more than a month prior to surgery) suffer from fewer physical limitations, less angina (crushing chest pain), and have a higher quality of life than smokers following coronary angioplasty, concludes a study supported in part by the Agency for Healthcare Research and Quality (HS11282).  more

 


*
Researchers examine medication effectiveness and depression among cardiac patients
Nearly 5 million people in the United States suffer from heart failure, a major cause of death. Depression, which affects many individuals who suffer from heart failure, heart attack, and other cardiac problems, increases the risk of further cardiac problems in these patients. A new study supported by the Agency for Healthcare Research and Quality (contract 290-97-0001) details medications that are effective for certain types of heart failure patients.  more

*
Physicians are more likely to intensify therapy for diabetes when they get unfavorable blood-sugar test results during visits
Controlling blood-sugar levels (keeping A1c less than 7 percent) can delay or prevent complications of both insulin-dependent (type 1) and noninsulin-dependent (type 2) diabetes. However, many patients continue to have inadequate glycemic control and are at risk for organ damage. Providers often fail to intensify diabetes therapy appropriately when patient glycemic control is poor.  more

*
National Emphysema Treatment Trial examines benefits and costs of lung-volume-reduction surgery for severe emphysema
Lung-volume-reduction surgery has been proposed as a palliative treatment for patients with severe emphysema. The National Emphysema Treatment Trial (NETT), cosponsored by the Agency for Healthcare Research and Quality, the National Heart, Lung, and Blood Institute, and the Centers for Medicare & Medicaid Services, compared the effectiveness and cost-effectiveness of lung-volume-reduction surgery with medical therapy for severe emphysema.  more

 
little clear gif used for a space